Celltrion
068270.KS
#748
Rank
HK$209.58 B
Marketcap
HK$973.92
Share price
0.61%
Change (1 day)
-8.31%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): HK$23.44

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$23.29. In 2022 the company made an earnings per share (EPS) of HK$22.68 a decrease over its 2021 EPS that were of HK$26.95.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$23.443.37%
2022HK$22.68-15.84%
2021HK$26.9512.77%
2020HK$23.8970.79%
2019HK$13.9915.63%
2018HK$12.10-33.13%
2017HK$18.09141.17%
2016HK$7.508.28%
2015HK$6.9311.28%
2014HK$6.2316.37%
2013HK$5.35-67.42%
2012HK$16.4384.22%
2011HK$8.9262.13%
2010HK$5.5080.61%
2009HK$3.05-559.63%
2008-HK$0.66-123.16%
2007HK$2.86